Cost–Utility of First-Line Actinic Keratosis Treatments in Finland

Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: four illustrative cases

(2014) C. Longo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

A Network Meta-Analysis of the Relative Efficacy of Treatments for Actinic Keratosis of the Face or Scalp in Europe

(2014) Stefan Vegter et al.   PLoS One

Long-term Follow-up Study of Ingenol Mebutate Gel for the Treatment of Actinic Keratoses

(2013) Mark Lebwohl et al.   JAMA Dermatology

The patient journey: a report of skin cancer care across Europe

(2012) M. Trakatelli et al.   BRITISH JOURNAL OF DERMATOLOGY

Ingenol Mebutate Gel for Actinic Keratosis

(2012) Mark Lebwohl et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quality of the Finnish Hospital Discharge Register: A systematic review

(2012) Reijo Sund   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group

(2011) A. Pflugfelder et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Qualidade de vida e localização da lesão em pacientes dermatológicos

(2010) Martha Wallig Brusius Ludwig et al.   ANAIS BRASILEIROS DE DERMATOLOGIA

Actinic keratosis: Facts and controversies

(2010) Christine J. Ko   CLINICS IN DERMATOLOGY

Economic evaluations based on decision models: A response to Muston et al.

(2010) Ed Wilson   JOURNAL OF DERMATOLOGICAL TREATMENT

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 2-week cycles

(2010) Neil Swanson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Imiquimod 2.5% and 3.75% for the treatment of actinic keratoses: Results of two placebo-controlled studies of daily application to the face and balding scalp for two 3-week cycles

(2010) C. William Hanke et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Non-melanoma skin cancer

(2010) Vishal Madan et al.   LANCET

Cost Effectiveness of Imiquimod 5% Cream Compared with Methyl Aminolevulinate-Based Photodynamic Therapy in the Treatment of Non-Hyperkeratotic, Non-Hypertrophic Actinic (Solar) Keratoses

(2010) Edward C.F. Wilson   PHARMACOECONOMICS

PEP005 (ingenol mebutate) gel, a novel agent for the treatment of actinic keratosis: Results of a randomized, double-blind, vehicle-controlled, multicentre, phase IIa study

(2009) Greg Siller et al.   AUSTRALASIAN JOURNAL OF DERMATOLOGY

Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial

(2009) K. Gebauer et al.   BRITISH JOURNAL OF DERMATOLOGY

Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies

(2009) A. Hauschild et al.   BRITISH JOURNAL OF DERMATOLOGY

Topical Methyl Aminolevulinate Photodynamic Therapy Using Red Light-Emitting Diode Light for Multiple Actinic Keratoses

(2009) Rolf-Markus Szeimies et al.   DERMATOLOGIC SURGERY

An economic evaluation of topical treatments for actinic keratosis

(2009) Dominic Muston et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Quality of life in the actinic neoplasia syndrome: The VA Topical Tretinoin Chemoprevention (VATTC) Trial

(2009) Martin A. Weinstock et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis

(2009) Lawrence Anderson et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Short incubation with methyl aminolevulinate for photodynamic therapy of actinic keratoses

(2009) LR Braathen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Pharmacoeconomic Considerations in Treating Actinic Keratosis

(2009) Marjorie V. Neidecker et al.   PHARMACOECONOMICS

Societal Cost of Skin Cancer in Sweden in 2005

(2008) G Tinghög et al.   ACTA DERMATO-VENEREOLOGICA

Multicentre intraindividual randomized trial of topical methyl aminolaevulinate–photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities

(2008) R. Kaufmann et al.   BRITISH JOURNAL OF DERMATOLOGY

Basal Cell Carcinomas and Actinic Keratoses Seen in Dermatological Practice in France: A Cross-Sectional Survey

(2008) P. Bernard et al.   DERMATOLOGY

Effective photodynamic therapy of actinic keratoses on the head and face with a novel, self-adhesive 5-aminolaevulinic acid patch

(2008) Axel Hauschild et al.   EXPERIMENTAL DERMATOLOGY

Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis

(2008) Osman Kose et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study

(2008) David Pariser et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY